PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y10. A total of 7 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $43,712,000 | – | 5,662,183 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 5,662,183 | $43,712,000 | 0.30% |
| Advanced Investment Partners, LLC | 8,982 | $74,000 | 0.13% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,427,324 | $11,019,000 | 0.08% |
| INGALLS & SNYDER LLC | 48,700 | $375,000 | 0.02% |
| NJ State Employees Deferred Compensation Plan | 8,000 | $62,000 | 0.01% |
| State of New Jersey Common Pension Fund A | 245,000 | $1,891,000 | 0.01% |
| DEUTSCHE BANK AG\ | 1,019,083 | $7,864,000 | 0.01% |